Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric Cancer
A Phase III Study of Docetaxel and S-1 Versus S-1 in the Treatment of Advanced Gastric Cancer
Sponsor: Japan Clinical Cancer Research Organization
Listed as NCT00287768, this PHASE3 trial focuses on Gastric Cancer and remains completed. Sponsored by Japan Clinical Cancer Research Organization, it has been updated 6 times since 2006, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE3
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE3
First recorded
Mar 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Japan Clinical Cancer Research Organization
- Korean Cancer Study Group
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Akita, Japan , Aomori, Japan , Asahikawa, Japan , Bunkyo-ku, Japan , Chiba, Japan , Chiyoda-ku, Japan , Chutougun, Japan , Ehime, Japan , Fukui-shi, Japan , Fukuoka, Japan and 71 more locations